Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IKBKB | O14920 | 3/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.54 |
| ▸ | NPC1 | O15118 | 3/20 | 0.54 |
| ▸ | RAB9A | P51151 | 3/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.54 |
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.47 |
| ▸ | SCN4A | P35499 | 1/20 | 0.44 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.44 |
| ▸ | LTA4H | P09960 | 4/20 | 0.43 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31609687 | 0.86 | ALDH1A1 (0.50) | IKBKBTDP1NPC1RAB9AL3MBTL1 | |
| SCHEMBL4640548 | 0.86 | ALDH1A1 (0.50) | IKBKBTDP1NPC1RAB9AL3MBTL1 | |
| SCHEMBL21944747 | 0.85 | TDP1 (0.45) | IKBKBTDP1NPC1RAB9AL3MBTL1 | |
| SCHEMBL18004134 | 0.85 | NPC1 (0.49) | IKBKBTDP1NPC1RAB9AL3MBTL1 | |
| SCHEMBL18003523 | 0.81 | NPC1 (0.52) | IKBKBTDP1NPC1RAB9AL3MBTL1 | |
| SCHEMBL22663 | 0.79 | CYP3A4 (0.59) | NPC1RAB9AL3MBTL1MAPTSMN1; SMN2 | |
| Toluene SCHEMBL11239856 | 0.78 | ALDH1A1 (0.49) | TDP1NPC1RAB9AL3MBTL1MAPT | |
| SCHEMBL24156360 | 0.77 | MEN1 (0.52) | IKBKBTDP1NPC1RAB9AL3MBTL1 | |
| SCHEMBL6003293 | 0.77 | SLC6A4 (0.47) | IKBKBTDP1NPC1RAB9AL3MBTL1 | |
| SCHEMBL23133 | 0.77 | NPC1 (0.57) | TDP1NPC1RAB9AL3MBTL1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024173715-A1 | ANTIFUNGAL COMPOSITIONS AND METHODS OF USE THEREOF | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2024-08-22 | — | — | WO | claimed |
| EP-4570313-A2 | CYANOTRIAZOLE COMPOUNDS | Otsuka Pharmaceutical Co., Ltd. (JP) | 2025-06-18 | — | — | EP | disclosed |
| EP-4219477-A1 | CYANOTRIAZOLE COMPOUNDS | Otsuka Pharmaceutical Co., Ltd. (JP) | 2023-08-02 | — | — | EP | disclosed |
| US-10626095-B2 | Cyanotriazole compounds | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2020-04-21 | — | — | US | disclosed |
| CN-105408325-B | cyanotriazole compounds | 大塚制药株式会社 | 2019-10-22 | — | — | CN | disclosed |
| US-20160229816-A1 | CYANOTRIAZOLE COMPOUNDS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2016-08-11 | — | — | US | disclosed |
| EP-3022199-A1 | CYANOTRIAZOLE COMPOUNDS | Otsuka Pharmaceutical Co., Ltd. (JP) | 2016-05-25 | — | — | EP | disclosed |
| CN-105408325-A | Cyanotriazole compounds | OTSUKA PHARMA CO LTD | 2016-03-16 | — | — | CN | disclosed |
| WO-2015008872-A1 | CYANOTRIAZOLE COMPOUNDS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2015-01-22 | — | — | WO | disclosed |
| EP-0607800-B1 | Photographic colour recording material | AGFA GEVAERT AG (DE) | 1999-04-07 | — | — | EP | disclosed |
| EP-0607801-B1 | Photographic colour recording material | AGFA GEVAERT AG (DE) | 1999-04-07 | — | — | EP | disclosed |
| US-5445928-A | Improved reproduction at high density with excellent color separation; using gap sensitizer in coupler-free layer containing silver halide emulsion | AGFA-GEVAERT AG (DE) | 1995-08-29 | — | — | US | disclosed |
| US-5437969-A | Improved definition, color separation at high densities | AGFA-GEVAERT AG (DE) | 1995-08-01 | — | — | US | disclosed |
| EP-0607800-A1 | Photographic colour recording material | Agfa-Gevaert AG (DE) | 1994-07-27 | — | — | EP | disclosed |
| EP-0607801-A1 | Photographic colour recording material | Agfa-Gevaert AG (DE) | 1994-07-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10626095-B2 | Cyanotriazole compounds | CS, PC, ACAT1 | IKBKB 1018/4885TDP1 2138/4885NPC1 1062/4885 |
| US-20160229816-A1 | CYANOTRIAZOLE COMPOUNDS | CS, PC, ACAT1 | IKBKB 1018/4885TDP1 2138/4885NPC1 1062/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.